B. Riley Securities served as exclusive financial advisor in connection with the sale of the PoNS® (Portable Neuromodulation Stimulator) System to Bioness Medical, Inc. 
 
The PoNS System is a medical device that helps patients recovering from neurological conditions – such as stroke, traumatic brain injury, and multiple sclerosis -- improve their ability to walk and maintain balance. It offers a non-surgical, non-drug approach to rehabilitation that can be used alongside traditional physical therapy. 

Bioness Medical is a leading provider of advanced rehabilitation technologies designed to restore mobility, function, and independence. The acquisition expands its platform into central neuromodulation, complementing an established portfolio that includes the L300 Go®, H200® Wireless, and Vector® Gait & Safety System. 

B. Riley Securities acted as exclusive financial advisor in connection with this transaction. The deal team was led by Thomas McGlynn and included Elise Melconian, Noah Rich, and Hughes Raiford.